7Baggers
 Published on: 2025-11-15 17:19:22  newser.com Sat, 15 Nov 2025 23:19:22 GMT
 Can-Fite BioPharma Shareholders Approve Key Proposals  TipRanks Mon, 10 Nov 2025 22:13:19 GMT
 published on: 2025-11-09 13:02:31  newser.com Sun, 09 Nov 2025 19:02:31 GMT
 can-fite biopharma (nyse:canf) upgraded at zacks research  Defense World Sun, 09 Nov 2025 07:16:06 GMT
 published on: 2025-11-06 03:42:35  newser.com Thu, 06 Nov 2025 09:42:35 GMT
 published on: 2025-11-05 22:42:10  newser.com Thu, 06 Nov 2025 04:42:10 GMT
 published on: 2025-11-05 01:34:03  newser.com Wed, 05 Nov 2025 07:34:03 GMT
 H.C. Wainwright assumes coverage on Can-Fite BioPharma stock with Buy rating  Investing.com Nigeria Tue, 04 Nov 2025 12:38:09 GMT
 can-fite biopharma assumed with a buy at h.c. wainwright  TipRanks Tue, 04 Nov 2025 11:52:54 GMT
 published on: 2025-11-04 02:34:00  newser.com Tue, 04 Nov 2025 08:34:00 GMT
 published on: 2025-11-04 01:59:26  newser.com Tue, 04 Nov 2025 07:59:26 GMT
 published on: 2025-11-02 03:47:43  newser.com Sun, 02 Nov 2025 08:47:43 GMT
 published on: 2025-11-01 02:23:45  newser.com Sat, 01 Nov 2025 07:23:45 GMT

Can-Fite BioPharma Ltd
(NYSE MKT:CANF) 

CANF stock logo

Can-Fite BioPharma Ltd., a clinical-stage biopharmaceutical company, develops small molecule therapeutic products for the treatment of cancer, liver and inflammatory disease, COVID-19 and erectile dysfunction. The company's lead drug candidate CF101 (Piclidenoson), which is in Phase III clinical tri...

Full Time Employees: 8
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends